IRRF - ISRS Congress
The International Radiosurgery Research Foundation
The ISRS is proud to announce that it has partnered with the International Radiosurgery Research Foundation (IRRF) on the IRRF’s 4th biennial meeting which will be held on June 18-20, 2020 at the Long Island Marriott Hotel on Long Island, New York. Dedicated exclusively to central nervous system radiosurgery, the meeting will include practical workshops and robust scientific presentations describing the results of collaborative studies, institutional results and ongoing research. The scientific directors of the meeting will be Michael Schulder, MD (site host), Douglas Kondziolka, MD representing IRRF, and John Suh, MD and Jason Sheehan, MD, PhD representing ISRS. Additional information regarding the program and registration details may be found: here. Founded in 2009, the International Radiosurgery Research Foundation (IRRF) is a 501(c)3 non-profit organization which in part facilitates retrospective and prospective clinical trials and outcomes analysis to evaluate and elucidate the role of stereotactic radiosurgery for a wide spectrum of clinical indications.
Originally formed as the North American Gamma Knife Consortium, the name was changed in 2018 as was its scope; the IRRF encompasses users of all types of radiosurgical devices and has a global membership comprising 37 academic and clinical centers of excellence from countries including United States, Canada, Czech Republic, Dominican Republic, Egypt, India, Taiwan and Turkey. Dedicated to education of clinicians, research and the public, the IRRF actively disseminates the results of its efforts. More than 60 articles describing the results of IRRF-conducted studies have been published in peer-reviewed medical journals, while dozens of abstracts have been presented at major congresses including the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, and the ISRS Congress. The IRRF has a unique ability to facilitate rigorous studies of both common and rare SRS indications. Topics addressed by collaborative studies have included common indications such as intracranial AVM’s as well as rare ones such as recurrent neuroesthesioblastoma, CNS lymphoma, ependymoma, and cluster headache. Specific aspects of SRS indications have been analyzed including: whole sellar SRS in Cushing’s Disease, dural AVFs, and SRS for meningiomas and vestibular schwannomas in NF-2 Patients and trigeminal neuralgia in patients with MS.
IRRF’s headquarters are currently located at University of Pittsburgh Medical Center. Ajay Niranjan, MD, MBA is the Executive Director and Gene Barnett (Chair), Jason Sheehan, MD, PhD (Vice Chair), Veronica Chiang, MD (Secretary-Treasurer) and L. Dade Lunsford, MD (Past Chair) currently serve as the board members of the executive committee.
More information regarding IRRF’s scientific initiatives including a bibliography of publications and ongoing studies can be found here: https://www.irr-f.org/.